GlaxoSmithKline Pharmaceuticals Limited

Rentabilité sur six mois: +65.63%
Rendement en dividendes: 1.89%

3 299.05 ₹

0 ₹ 0%
1956.25 ₹
3459.7 ₹

paper.min_max_per_year

Calendrier des promotions GlaxoSmithKline Pharmaceuticals Limited

À propos de l'entreprise GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines comprising NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, which are antibiotics to treat bacterial infections; CALPOL for treatment of mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment and prevention of specific bacterial skin infections; BETNOVATE for skin conditions which require relief of inflammation; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin and dry skin associated with redness and itch. Further, it develops products for infectious diseases, HIV, oncology, and immunology. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Paramètres de base

ISIN
INE159A01016
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
2.61
Дивиденд ао
42
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 9.63 1
P/BV 18.71 1
P/E 56.38 2
Efficacité
Nom Signification Grade
ROA 17.14 5
ROE 33.53 9
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 1.89 4.73
DSI 0.8571 8.57
Croissance moyenne du dividende 13.33 10
Devoir
Nom Signification Grade
Debt/EBITDA 0.0172 10
Debt/Ratio 0.0044 10
Debt/Equity 1 8
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 17.2 3
Rentabilité Ebitda, % 23.53 4
Rentabilité EPS, % 159 10

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 3 299.05 ₹ 0 ₹ 0 ₹ 0 % 0 % 0 %
common.calendar.number_days.7d 3 396.15 ₹ 0 ₹ 0 ₹ -2.86 % 0 % 0 %
common.calendar.number_days.30d 3 021.55 ₹ 3 299.05 ₹ 3 299.05 ₹ +9.18 % 0 % 0 %
common.calendar.number_days.90d 2 675.05 ₹ 2 721.25 ₹ 3 459.7 ₹ +23.33 % 0 % 0 %
common.calendar.number_days.180d 1 991.8 ₹ 1 956.25 ₹ 3 459.7 ₹ +65.63 % 0 % 0 %
common.calendar.number_days.1y 2 874.5 ₹ 1 956.25 ₹ 3 459.7 ₹ +14.77 % 0 % 0 %
common.calendar.number_days.3y 1 459.8 ₹ 1 230.9 ₹ 3 459.7 ₹ +125.99 % 0 % 0 %
common.calendar.number_days.5y 1 456.5 ₹ 1 230.9 ₹ 3 459.7 ₹ +126.51 % 0 % 0 %
common.calendar.number_days.10y 1 119.85 ₹ 1 119.85 ₹ 3 812.7 ₹ +294.6 % 0 % 0 %
common.calendar.number_days.ytd 2 062.95 ₹ 1 956.25 ₹ 3 459.7 ₹ +59.92 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Bhushan Akshikar MD & Executive Director 32.37M
Mr. Juby Chandy Whole-Time Director & CFO 54.12M 1977 (48 années)
Mr. Amit G. Pandey Executive Vice President of Legal N/A
Ms. Simrat Sohal Vice President of Ethics & Compliance N/A
Mr. Chinmay Sharma Executive Vice President of Human Resources N/A
Ms. Sukanya Choudhary Executive Vice-President of Regulatory Affairs N/A
Ms. Aparajita Rajput Vice President of Technology
Mr. Ajay Avinash Nadkarni VP of Administration & Real Estate and Company Secretary
Mr. Ransom D'Souza Executive Vice President of Communications & Government Affairs
Mr. Shourov Mukherjee Executive Vice-President of Adult Vaccines

Informations sur l'entreprise

Adresse: India, Mumbai, GSK House - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://india-pharma.gsk.com